Altered Functioning of Cognitive and Affective Circuits in Late-Life Depression
Altered Functioning of Cognitive and Affective Circuits in Late-Life Depression
批准号:
7383129
负责人:
HOWARD J AIZENSTEIN
金额:
$31.96万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2011-03-31
关键词:
AffectiveAgeAgingAlzheimer&aposs DiseaseAmygdaloid structureAnteriorAntidepressive AgentsBeliefBiologicalBiological FactorsBrainBrain regionCerebrovascular DisordersCognitionCognitiveDataDepressed moodDepressive SyndromesDiagnosisDiffusion Magnetic Resonance ImagingDiseaseDistressDorsalElderlyEscitalopramExpressed EmotionFaceFunctional Magnetic Resonance ImagingFutureGoalsGrantHealth Services ResearchHeart DiseasesHeterogeneityHippocampus (Brain)Impaired cognitionIndividualInterventionIntervention StudiesJointsK-Series Research Career ProgramsLateralLeadLinkMRI ScansMeasuresMedialMediatingMedicalMemoryMental DepressionMethodsModelingMood DisordersNerve DegenerationNeural PathwaysNeuroanatomyNeurobiologyNumbersOutcomePathway interactionsPatientsPharmacotherapyPilot ProjectsPrefrontal CortexPreventionProcessPublic HealthRateResearchResearch InfrastructureResearch PersonnelResistanceSamplingScanningSignal TransductionStructureSubgroupSuicideTemporal LobeTestingTimeWeekadjudicateagedbaseburden of illnesscerebrovascularcingulate cortexcognitive changecognitive controlcognitive functiondemographicsdepressive symptomsdesigndisabilityexecutive functiongeriatric depressiongeriatric major depressionimprovedinterestmemory encodingmiddle ageneural circuitneuropsychologicalrelating to nervous systemresearch studyresponsetheorieswhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Depression in the elderly is complicated by both cerebrovascular disease and neurodegeneration, both of which are believed to contribute to the limited efficacy of antidepressant treatment in the elderly. However, the neurobiologic basis of the depressive syndrome and treatment response in late-life depression have not been established. The primary aim of this R01 application is to characterize the functional neuroanatomy of geriatric major depression, which we believe is characterized by altered functional connectivity, and use this to explain treatment response variability. The proposed study will identify in elderly individuals the changes in regional brain activity associated with being depressed, being treated for depression, and responding to depression treatment. To this end we will investigate, with fMRI, eighty elderly depressed subjects and 40 elderly controls. Subjects will undergo fMRI scanning on two occasions 12 weeks apart. For the depressed subjects, the scanning will occur just before and 12 weeks after initiating treatment with escitalopram. The depressed subjects will be restricted to individuals aged 65 and older, whose first episode of depression started at age 60 or older. We limit our sample to these 'late-onset' elderly depression subjects because, by definition, these individuals did not have mid-life depression, and thus should be most likely to show late-life specific biological factors. Our fMRI tasks target three of the key cognitive and affective neural pathways associated with LLD: a) cognitive control, b) declarative memory, and c) affective reactivity. These are central to theories of LLD and are associated with specific brain regions that have been linked to the neurobiology of LLD: the lateral prefrontal cortex (LPFC), the dorsal anterior cingulate cortex (dACC); the medial temporal lobe (MTL), and the amygdala. In the specific tasks, subjects will inhibit a prepotent response (cognitive control), recognize previously seen words (declarative memory), and respond to faces expressing emotion (affective reactivity). Functional connectivity, as well regional activity, will be estimated using the BOLD fMRI signal. The results of this study will characterize the functional neuroanatomy of late- life depression, which will be used to explain why some patients do not respond well to anti-depressant treatment. These treatment response subgroups can then serve as targets for future prevention and treatment studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis
-
批准号:10738869
-
项目类别:
-
资助金额:$143.41万
-
财政年份:2023
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10590719
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10161693
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10410389
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10652258
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:10343792
-
项目类别:
-
资助金额:$73.76万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:9912701
-
项目类别:
-
资助金额:$73.35万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10202409
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:10549382
-
项目类别:
-
资助金额:$75.04万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:9765902
-
项目类别:
-
资助金额:$76.32万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10397601
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:10506442
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:9405041
-
项目类别:
-
资助金额:$60.88万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:10084318
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:9234742
-
项目类别:
-
资助金额:$59.13万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with Depression
-
批准号:9352370
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2016
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with Depression
-
批准号:9196861
-
项目类别:
-
资助金额:$68.55万
-
财政年份:2016
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Resilience to Mobility Impairment: Neural Correlates and Protective Factors
-
批准号:9085177
-
项目类别:
-
资助金额:$13.62万
-
财政年份:2015
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Ultra-high-field neuroimaging in elderly after a two-year exercise intervention
-
批准号:8910602
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2014
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Ultra-high-field neuroimaging in elderly after a two-year exercise intervention
-
批准号:9084465
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2014
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: